Under construction – not a live service
Sign in
Taking people in RussiaNo phase

Blood and urine chemical profiles in teenagers with asthma

Looks for blood and urine markers of asthma flare-ups in teenagers.

Plain-language title generated from the registry record
Registry title: Metabolomics in the Diagnosis and Treatment of Asthma in Children

Key facts

Where
Moscow, RussiaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 12 and 17 years old?

Source: NCT07280364, who can take part

Where in Russia

  • I.M. Sechenov First Moscow State Medical University (Sechenov University)Moscow, RussiaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
I.M. Sechenov First Moscow State Medical University
Trial code
NCT07280364
Record updated
28 January 2026
Original description
The goal of this observational study is to learn about the metabolomic profile of blood and urine in children 12-17 years with asthma. The main question it aims to answer is:Read full original descriptionShow less

Metabolomics in the Diagnosis and Treatment of Asthma in Children

The goal of this observational study is to learn about the metabolomic profile of blood and urine in children 12-17 years with asthma. The main question it aims to answer is:

• Are there metabolites in the blood and urine that are specific for asthma exacerbation? Participants already receive standard therapy as part of their regular medical care for asthma.

Inclusion: Age from 12 to 17 years old; Confirmed diagnosis of asthma; Informed voluntary consent to participate in the study.

Exclusion: concomitant severe somatic, metabolic, and endocrine diseases; age under 12 years; no established diagnosis of asthma; patient's withdrawal of informed consent.

ClinicalTrials.gov NCT07280364